Furthermore, the documented roles of TP53TG1 in glioma cell proliferation [57] and response to chemotherapy in lung cancer [58] provide experimental support for our in silico prediction of a role for TP53TG1 in the response of GBM cells to TMZ. This evidence concerns the gene TP53TG1 and lung cancer.